Table 3.
Follow up of patients without PCA.
| Initial | ≤ 12 M | 12–24 M | 25–36 M | p-value | |
|---|---|---|---|---|---|
|
Number n |
70 | 25 | 46 | 23 | |
|
PSA Median (IQR), ng/ml |
8.4 (5.5–11) | 7.3 (5.0–10.3) | 8.3 (5.7–12.3) | 8.5 (7.1–13.4) | 0.24 |
|
PSAD Median (IQR), ng/ml/cm3 |
0.13 (0.09–0.17) | 0.14 (0.11–0.17) | 0.11 (0.09–0.21) | 0.13 (0.09–0.2) | 0.06 |
|
Volume Median (IQR), ml |
68 (47–91) | 53 (39–66) | 67 (48–88) | 69 (51–80) | 0.08 |
|
PI-RADS Median (mean) |
3 (3.0) | 3 (2.84) | 3 (2.93) | 3 (2.78) | 0.02 |
|
M mean ± SD |
10 ± 2 | 18 ± 3 | 30 ± 3 | ||
PSA value: prostate specific antigen; PSAD: prostate specific antigen density; PI-RADS: Prostate Imaging Reporting and Data System; IQR: interquartile range; M: months; n: number.
Significant values are given in bold.